Developmental expression of P5 ATPase mRNA in the mouse

Cellular and Molecular Biology Letters

Volumn 17, Issue 1, 2012, Pages 153-170

  Weingarten, Lisa S ^a   Dave, Hardi ^b   Li, Hongyan ^b   Crawford, Dorota A ^a,b  

^a YORK UNIVERSITY   (Canada)

^b York University   (Canada)

Author keywords

Autism spectrum disorders; Immunohistochemistry; mRNA expression; Neurogenesis; Parkinson's disease; Real time PCR

Indexed keywords

ADENOSINE TRIPHOSPHATASE; MESSENGER RNA; PROTEIN ATP13A1; PROTEIN ATP13A2; PROTEIN ATP13A3; PROTEIN ATP13A4; PROTEIN ATP13A5; UNCLASSIFIED DRUG; ATP13A4 PROTEIN, MOUSE; ISOPROTEIN;

ADULT ANIMAL; ANIMAL TISSUE; ARTICLE; ATP13A1 GENE; ATP13A2 GENE; ATP13A3 GENE; ATP13A4 GENE; ATP13A5 GENE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN REGION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DEVELOPMENTAL GENE; DOWN REGULATION; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; UPREGULATION; ANIMAL; BRAIN; C57BL MOUSE; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY;

EUKARYOTA;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BRAIN; EMBRYONIC DEVELOPMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; NEUROGENESIS; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 84859897722     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-011-0039-3     Document Type: Article

References (37)

1. Lutsenko, S. and Kaplan, J. H. Organization of P-type ATPases: significance of structural diversity. Biochemistry (N. Y.)48 (1995) 15607-15613.
2. Axelsen, K. B. and Palmgren, M. G. Evolution of substrate specificities in the P-type ATPase superfamily. J. Mol. Evol. 1 (1998) 84-101.
3. Kuhlbrandt, W. Biology, structure and mechanism of P-type ATPases. Nat. Rev. Mol. Cell Biol. 4 (2004) 282-295.
4. Paulusma, C. C. and Oude Elferink, R. P. The type 4 subfamily of P-type ATPases, putative aminophospholipid translocases with a role in human disease. Biochim. Biophys. Acta1-2 (2005) 11-24.
5. Folmer, D. E., Elferink, R. P. and Paulusma, C. C. P4 ATPases - lipid flippases and their role in disease. Biochim. Biophys. Acta7 (2009) 628-635.
6. Cronin, S. R., Khoury, A., Ferry, D. K. and Hampton, R. Y. Regulation of HMG-CoA reductase degradation requires the P-type ATPase Cod1p/Spf1p. J. Cell Biol. 5 (2000) 915-924.
7. 2+ homeostasis. J. Cell Biol. 6 (2002) 1017-1028.
8. Vallipuram, J., Grenville, J. and Crawford, D. A. The E646D-ATP13A4 mutation associated with autism reveals a defect in calcium regulation. Cell. Mol. Neurobiol. 30 (2010) 233-246.
9. Suzuki, C. and Shimma, Y. I. P-type ATPase spf1 mutants show a novel resistance mechanism for the killer toxin SMKT. Mol. Microbiol. 4 (1999) 813-823.
10. Vashist, S., Frank, C. G., Jakob, C. A. and Ng, D. T. Two distinctly localized p-type ATPases collaborate to maintain organelle homeostasis required for glycoprotein processing and quality control. Mol. Biol. Cell11 (2002) 3955-3966.
11. Jakobsen, M. K., Poulsen, L. R., Schulz, A., Fleurat-Lessard, P., Moller, A., Husted, S., Schiott, M., Amtmann, A. and Palmgren, M. G. Pollen development and fertilization in Arabidopsis is dependent on the MALE GAMETOGENESIS IMPAIRED ANTHERS gene encoding a type V P-type ATPase. Genes Dev. 22 (2005) 2757-2769.
12. Suzuki, C. Immunochemical and mutational analyses of P-type ATPase Spf1p involved in the yeast secretory pathway. Biosci. Biotechnol. Biochem. 11 (2001) 2405-2411.
13. Rand, J. D. and Grant, C. M. The thioredoxin system protects ribosomes against stress-induced aggregation. Mol. Biol. Cell1 (2006) 387-401.
14. Moller, A. B., Asp, T., Holm, P. B. and Palmgren, M. G. Phylogenetic analysis of P5 P-type ATPases, a eukaryotic lineage of secretory pathway pumps. Mol. Phylogenet. Evol. 2 (2008) 619-634.
15. Kwasnicka-Crawford, D. A., Carson, A. R., Roberts, W., Summers, A. M., Rehnstrom, K., Jarvela, I. and Scherer, S. W. Characterization of a novel cation transporter ATPase gene (ATP13A4) interrupted by 3q25-q29 inversion in an individual with language delay. Genomics2 (2005) 182-194.
16. Schultheis, P. J., Hagen, T. T., O'Toole, K. K., Tachibana, A., Burke, C. R., McGill, D. L., Okunade, G. W. and Shull, G. E. Characterization of the P5 subfamily of P-type transport ATPases in mice. Biochem. Biophys. Res. Commun. 3 (2004) 731-738.
17. Ramirez, A., Heimbach, A., Grundemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A. L., Roeper, J., Al-Din, A., Hillmer, A. M., Karsak, M., Liss, B., Woods, C. G., Behrens, M. I. and Kubisch, C. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 10 (2006) 1184-1191.
18. Di Fonzo, A., Chien, H. F., Socal, M., Giraudo, S., Tassorelli, C., Iliceto, G., Fabbrini, G., Marconi, R., Fincati, E., Abbruzzese, G., Marini, P., Squitieri, F., Horstink, M. W., Montagna, P., Libera, A. D., Stocchi, F., Goldwurm, S., Ferreira, J. J., Meco, G., Martignoni, E., Lopiano, L., Jardim, L. B., Oostra, B. A., Barbosa, E. R. and Bonifati, V. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology19 (2007) 1557-1562.
19. Lin, C. H., Tan, E. K., Chen, M. L., Tan, L. C., Lim, H. Q., Chen, G. S. and Wu, R. M. Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore. Neurology21 (2008) 1727-1732.
20. Rakovic, A., Stiller, B., Djarmati, A., Flaquer, A., Freudenberg, J., Toliat, M. R., Linnebank, M., Kostic, V., Lohmann, K., Paus, S., Nurnberg, P., Kubisch, C., Klein, C., Wullner, U. and Ramirez, A. Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease. Mov. Disord. 3 (2009) 429-433.
21. Santos, A. R. and Duarte, C. B. Validation of internal control genes for expression studies: effects of the neurotrophin BDNF on hippocampal neurons. J. Neurosci. Res. 16 (2008) 3684-3692.
22. de Kok, J. B., Roelofs, R. W., Giesendorf, B. A., Pennings, J. L., Waas, E. T., Feuth, T., Swinkels, D. W. and Span, P. N. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab. Invest. 1 (2005) 154-159.
23. Thal, S. C., Wyschkon, S., Pieter, D., Engelhard, K. and Werner, C. Selection of endogenous control genes for normalization of gene expression analysis after experimental brain trauma in mice. J. Neurotrauma7 (2008) 785-794.
24. Mwacharo, J., Dunachie, S. J., Kai, O., Hill, A. V., Bejon, P. and Fletcher, H. A. Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine. PloS One12 (2009) e8434.
25. Xing, W., Deng, M., Zhang, J., Huang, H., Dirsch, O. and Dahmen, U. Quantitative evaluation and selection of reference genes in a rat model of extended liver resection. J. Biomol. Tech. 2 (2009) 109-115.
26. Boda, E., Pini, A., Hoxha, E., Parolisi, R. and Tempia, F. Selection of reference genes for quantitative real-time RT-PCR studies in mouse brain. J. Mol. Neurosci. 3 (2009) 238-253.
27. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., van Roy, N., De Paepe, A. and Speleman, F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) RESEARCH0034.
28. Daston, G., Faustman, E., Ginsberg, G., Fenner-Crisp, P., Olin, S., Sonawane, B., Bruckner, J., Breslin, W. and McLaughlin, T. J. A framework for assessing risks to children from exposure to environmental agents. Environ. Health Perspect. 2 (2004) 238-256.
29. Rodier, P. M. Chronology of neuron development: animal studies and their clinical implications. Dev. Med. Child Neurol. 4 (1980) 525-545.
30. Angevine, J. B., Jr. Time of neuron origin in the diencephalon of the mouse. An autoradiographic study. J. Comp. Neurol. 2 (1970) 129-187.
31. Gerfen, C. R., Baimbridge, K. G. and Thibault, J. The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J. Neurosci. 12 (1987) 3935-3944.
32. Bayer, S. A., Wills, K. V., Triarhou, L. C. and Ghetti, B. Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Exp. Brain Res. 2 (1995) 191-199.
33. Kawano, H., Ohyama, K., Kawamura, K. and Nagatsu, I. Migration of dopaminergic neurons in the embryonic mesencephalon of mice. Brain Res. Dev. Brain Res. 1-2 (1995) 101-113.
34. Carper, R. A., Moses, P., Tigue, Z. D. and Courchesne, E. Cerebral lobes in autism: early hyperplasia and abnormal age effects. Neuroimage4 (2002) 1038-1051.
35. Carper, R. A. and Courchesne, E. Localized enlargement of the frontal cortex in early autism. Biol. Psychiatry2 (2005) 126-133.
36. Courchesne, E., Saitoh, O., Yeung-Courchesne, R., Press, G. A., Lincoln, A. J., Haas, R. H. and Schreibman, L. Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism: identification of hypoplastic and hyperplastic subgroups with MR imaging. AJR Am. J. Roentgenol. 1 (1994) 123-130.
37. Hashimoto, T., Tayama, M., Murakawa, K., Yoshimoto, T., Miyazaki, M., Harada, M. and Kuroda, Y. Development of the brainstem and cerebellum in autistic patients. J. Autism Dev. Disord. 1 (1995) 1-18.